Gabapentin can reduce your desire to drink and can help you stop drinking. Gabapentin may also help improve symptoms of anxiety and difficulty sleeping that may occur when stopping alcohol use. How does gabapentin work? • Gabapentin works on your brain to reduce your desire to drink alcohol. Gabapentin for alcohol use disorder: Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use disorder, a new study suggests. Some doctors use gabapentin and other medications to help treat alcohol withdrawal and alcohol use disorder. Though an off-label use, gabapentin has also been found useful in treating certain mental health disorders. 3 So, during addiction treatment, a person could be prescribed gabapentin to help with symptoms of cannabis, opioid, or alcohol use disorders or to help with co-occurring mental disorders such as anxiety, post-traumatic stress disorder Gabapentin is a calcium channel GABAergic modulator that is widely used for pain. Studies showing reduced drinking and decreased craving and alcohol-related disturbances in sleep and affect in the months following alcohol cessation suggest therapeutic potential for alcohol use disorder. Gabapentin is efficacious for the treatment of acute alcohol withdrawal symptoms 29,30 and also provides short-term relapse prevention after medicated alcohol detoxification, 31 perhaps by an effect on sleep normalization. 32,33 Post hoc analysis has shown effectiveness of treatment with gabapentin, in combination with flumazenil 34 or Both gabapentin and alcohol have sedative effects, so taking them together can make you even more sleepy, lightheaded, and clumsy. How Does Gabapentin Affect Alcohol? It is important to note that gabapentin does not tackle the underlying reasons for alcohol addiction. Is gabapentin an effective treatment for alcohol use disorder (AUD)? Gabapentin treatment avoided more heavy drinking days (> 5 standard drinks/day) than placebo (27% vs 9%). Gabapentin can be a second-line, off-label option to treat AUD. However, there is mixed evidence and concerns about abuse- In a 28‐day, placebo‐controlled, randomized, double‐blind clinical trial, investigators found that gabapentin (300 mg, twice daily) can reduce AUD patients’ number of drinks per day, the mean percentage of heavy drinking days, craving for alcohol, and increased percentage of days of abstinence in the gabapentin group than those in the Some studies suggest that BZD use may increase craving and early relapse to alcohol use, 17 whereas other studies 28,32,33 have shown that gabapentin use did not trigger alcohol craving. While gabapentin is not yet an FDA-approved treatment for alcoholism, a number of studies support the its use withdrawal and cravings: In a 12-day study detoxifying with either gabapentin or lorazepam (a benzodiazepine prescribed with the brand name Ativan), the former was less likely to drink – and had less craving, anxiety, and sedation. Alcohol misuse is the fifth leading risk factor for premature death and disability worldwide. Fewer than 10% of afflicted Americans receive pharmacological treatment for alcohol use disorder. Gabapentin is a calcium channel GABAergic modulator that is widely used for pain. Studies showing reduced dr In ClinicalTrials.gov, gabapentin was used as the search term with the following conditions: “alcohol dependence” (11 studies), “alcoholism” (11 studies), “alcohol-related disorders” (10 studies), “alcohol use disorder” (4 studies), and “heavy drinking” (2 studies). We also searched the reference sections of relevant Conducted by scientists supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, the study found that alcohol dependent patients using gabapentin were more likely to stop drinking or refrain from heavy drinking than those taking placebo. GABAPENTIN AND ALCOHOL USE DISORDER No effect was found of gabapentin use for benzodiazepine treatment of alcohol withdrawal. It is notable that Bonnet et al and Nichols et al had similar fi ndings despite their studies being conducted in different countries using distinct comparators and methods. Bonnet et al,27 in another study, tried The following variables assessed alcohol use severity and history: years of regular drinking (current age – age of onset); AUD symptom count via the DSM-5; alcohol craving measured through the Alcohol Craving Questionnaire (Singleton et al. 1994); negative drinking-related consequences score assessed via the ImBIBE, which is an adaptation of
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() |